Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Brooks Macdonald starts trading on main market

(Sharecast News) - Brooks Macdonald shares started trading on London's main market on Friday, following their simultaneous cancellation from AIM. The company said the move, which was implemented via an introduction of its existing shares, did not involve any fundraising or issuance of new shares.

It said its ordinary shares were admitted to the Equity Shares (Commercial Companies) category of the FCA's Official List, and retained their existing ISIN and ticker symbol.

Brooks Macdonald said the admission was intended to support its long-term growth strategy and enhance the profile and liquidity of its shares.

Following admission, the company's issued share capital comprised 16,382,539 shares, with none held in treasury.

"The move will enhance the Group's corporate profile and broaden our shareholder base," said chief executive officer Andrea Montague.

"This marks the start of a new chapter, and I am excited about us making the most of the opportunities in the UK wealth market to deliver for all our stakeholders."

At 0953 GMT, shares in Brooks Macdonald Group were down 0.34% at 1,480p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.